Liu Y - Search Results

1

Sphincter of Oddi laxity: an important factor in hepatolithiasis.

Liang TB, Liu Y, Bai XL, Yu J, Chen W. Liang TB, et al. Among authors: liu y. World J Gastroenterol. 2010 Feb 28;16(8):1014-8. doi: 10.3748/wjg.v16.i8.1014. World J Gastroenterol. 2010. PMID: 20180243 Free PMC article.

2

N1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2.

Yao M, Hong Y, Liu Y, Chen W, Wang W. Yao M, et al. Among authors: liu y. Exp Ther Med. 2017 Sep;14(3):2101-2107. doi: 10.3892/etm.2017.4740. Epub 2017 Jul 9. Exp Ther Med. 2017. PMID: 28962130 Free PMC article.

3

EIF5A2 is a novel chemoresistance gene in breast cancer.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Breast Cancer. 2015 Nov;22(6):602-7. doi: 10.1007/s12282-014-0526-2. Epub 2014 Mar 18. Breast Cancer. 2015. PMID: 24638963

4

G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.

Liu Y, Du FY, Chen W, Fu PF, Yao MY, Zheng SS. Liu Y, et al. Am J Transl Res. 2015 May 15;7(5):967-75. eCollection 2015. Am J Transl Res. 2015. PMID: 26175858 Free PMC article.

5

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Exp Cell Res. 2013 Dec 10;319(20):3140-9. doi: 10.1016/j.yexcr.2013.08.023. Epub 2013 Sep 3. Exp Cell Res. 2013. PMID: 24012960

6

Pelargonidin-3-O-rutinoside as a novel α-glucosidase inhibitor for improving postprandial hyperglycemia.

Xu Y , Xie L , Xie J , Liu Y , Chen W . Xu Y , et al. Among authors: liu y. Chem Commun (Camb). 2018 Dec 18;55(1):39-42. doi: 10.1039/c8cc07985d. Chem Commun (Camb). 2018. PMID: 30394469

7

Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.

Fu P, Du F, Chen W, Yao M, Lv K, Liu Y. Fu P, et al. Among authors: liu y. Oncol Rep. 2014 Jun;31(6):2561-8. doi: 10.3892/or.2014.3140. Epub 2014 Apr 16. Oncol Rep. 2014. PMID: 24737252

8

miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.

Du F, Yu L, Wu Y, Wang S, Yao J, Zheng X, Xie S, Zhang S, Lu X, Liu Y, Chen W. Du F, et al. Among authors: liu y. Cell Death Dis. 2019 Dec 4;10(12):922. doi: 10.1038/s41419-019-2164-2. Cell Death Dis. 2019. PMID: 31801953 Free PMC article.

9

Interactions Between lncRNA TUG1 and miR-9-5p Modulate the Resistance of Breast Cancer Cells to Doxorubicin by Regulating eIF5A2.

Wang S, Cheng M, Zheng X, Zheng L, Liu H, Lu J, Liu Y, Chen W. Wang S, et al. Among authors: liu y, liu h. Onco Targets Ther. 2020 Dec 23;13:13159-13170. doi: 10.2147/OTT.S255113. eCollection 2020. Onco Targets Ther. 2020. PMID: 33380806 Free PMC article.

10

Adult intussusception: a retrospective review of 41 cases.

Wang N, Cui XY, Liu Y, Long J, Xu YH, Guo RX, Guo KJ. Wang N, et al. Among authors: liu y. World J Gastroenterol. 2009 Jul 14;15(26):3303-8. doi: 10.3748/wjg.15.3303. World J Gastroenterol. 2009. PMID: 19598308 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,193 results

Search Page

Filters